Home
About
Overview
Sharing Data
ORCID
Help
History (83)
Noncanonical Valpha24JalphaQ T cells with conservative alpha chain CDR3 region amino acid substitutions are restricted by CD1d.
Declining length of hospital stay for acute myocardial infarction and postdischarge outcomes: a community-wide perspective.
Occupational biomechanical risk factors for surgically treated ulnar nerve entrapment in a prospective study of male construction workers.
Translational behavior analysis: from laboratory science in stimulus control to intervention with persons with neurodevelopmental disabilities.
HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke.
See All 83 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke.
Moonis M, Fisher M. HMG CoA reductase inhibitors (statins): use in stroke prevention and outcome after stroke. Expert Rev Neurother. 2004 Mar; 4(2):241-7.
View in:
PubMed
subject areas
Animals
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Randomized Controlled Trials as Topic
Stroke
Treatment Outcome
authors with profiles
Majaz Moonis MD